Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

MONOGRAM BIOSCIENCES, INC.

MONOGRAM BIOSCIENCES, INC. is a federal contractor, registered under UEI LFM3XDVK31M7 and CAGE code 3XFL0. It has been awarded $53,829,824 in federal contracts. Primary work spans Research and Development in Biotechnology (except Nanobiotechnology), Unknown NAICS, and Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Top awarding agencies include Department Of Health And Human Services, Department Of Veterans Affairs, and Department Of Health And Human Services (hhs).

Contact Information

Registration and classification details

Registration

UEI Code

LFM3XDVK31M7

CAGE Code

3XFL0

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit Organization

NAICS Codes

541714Research and Development in Biotechnology (except Nanobiotechnology)
621511Medical Laboratories(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Monogram Biosciences, Inc. specializes in high-throughput immunological assay development and clinical laboratory services focused on infectious disease diagnostics and biotechnological research. Their core capabilities include the design and validation of neutralizing antibody assays for SARS-CoV-2...

Monogram Biosciences, Inc. specializes in high-throughput immunological assay development and clinical laboratory services focused on infectious disease diagnostics and biotechnological research. Their core capabilities include the design and validation of neutralizing antibody assays for SARS-CoV-2 variants, leveraging serological testing of human serum samples to characterize immune responses and viral evolution. The company applies advanced immunoassay platforms and molecular diagnostics to support public health surveillance and therapeutic evaluation, with technical expertise in virology, antibody kinetics, and automated sample processing systems. Their differentiation lies in bridging research-scale biotechnology development with accredited clinical laboratory workflows, enabling rapid translation of assay prototypes into validated diagnostic tools for regulatory and public health use. The contractor has delivered services exclusively to the Department of Health and Human Services, supporting both research and operational laboratory functions. Their engagements center on pandemic response initiatives, including the development of diagnostic assays for emerging variants and the closeout of clinical testing programs, indicating a consistent role in HHS’s public health emergency preparedness and response infrastructure. Monogram Biosciences operates primarily under NAICS 541714 for biotechnology R&D and 621511 for medical laboratories, positioning itself at the intersection of applied bioscience innovation and clinical diagnostics. The company focuses on infectious disease analytics, immune profiling, and assay validation—areas critical to federal health security and vaccine efficacy monitoring. As a small business structured as a 2L entity, Monogram Biosciences is headquartered in South San Francisco, California, leveraging proximity to biotech innovation hubs. While no government certifications are listed, their work aligns with CLIA and CAP standards through clinical laboratory operations, and their geographic base supports strong integration with federal health research networks in the Bay Area.

Key Performance Metrics

Awards Count

152

All time

Active

1

Currently performing

Completed

151

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by Agency Over Time
Awards by Place of Performance

Compete with MONOGRAM BIOSCIENCES, INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for MONOGRAM BIOSCIENCES, INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in MONOGRAM BIOSCIENCES, INC.'s top NAICS codes and agencies

NAICS: 541715
New
Federal
Mobile Integrated Launch Capability
Solicitation # 26-MDA-12366
The Missile Defense Agency (MDA) is soliciting innovative and cost-efficient alternatives to current C-17 air drop target launches through the Mobile Integrated Launch Capability (MILC) program. The objective is to develop mobile launch platforms capable of deploying short to long-range target missile systems, including ballistic, air-breathing, and maneuvering targets, from various global locations via ground, sea, or air. This effort is structured in two phases: Phase I focuses on detailed design, engagement analysis, and prototype costing with an objective period of three months; Phase II involves prototyping, ground testing, and the delivery of one launch platform for a demonstration launch, with an objective period of twelve months. The solicitation follows a two-step competitive process based on the evaluation of white papers, which are judged on technical merit, innovation, potential utility to agency programs, schedule adherence, and lifecycle cost. Offerors must be registered in the System for Award Management and maintain an active Secret Facility Clearance to handle classified information. Procurement may be executed through Revolutionary Federal Acquisition Regulation (RFO) based contracts or Other Transaction (OT) agreements, the latter of which prioritize commercial industry standards. Submissions must include a detailed program plan, a Rough Order of Magnitude cost estimate, and a full disclosure of any organizational conflicts of interest.
Missile Defense Agency (mda)

POSTED

4 days ago

DEADLINE

in almost 2 years
View Details
NAICS: 621511
New
Federal
Q301-- New Lab Staffing Contract Fiscal Year 2027-Path & Lab
Solicitation # 36C24926Q0334_1
The Department of Veterans Affairs, Network Contracting Office 9, is soliciting quotes for a five-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract to provide laboratory staffing services at the Lt. Col Luke Weathers Jr. VAMC in Memphis, Tennessee. The performance period runs from April 1, 2027, to March 31, 2032, with a total estimated value of 41.5 million dollars. This procurement is a 100 percent set-aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSBs). The contractor is required to provide up to 16 full-time equivalent key personnel to support three daily shifts, with a guaranteed minimum of 3,402 hours and a maximum not to exceed 340,240 hours. Award will be based on a best-value determination using comparative analysis of administrative compliance, past performance, technical capability, and price. Technical evaluation specifically emphasizes the quality of certifications and the effectiveness of the contractor's contingency plan for ensuring uninterrupted services. Contractors must adhere to strict clinical standards, including JCAHO, CAP, FDA, and CLIA regulations, and comply with all VA security, confidentiality, and HIPAA requirements. Proposals must be submitted electronically by October 14, 2026, and must include specific certifications regarding the Immigration and Nationality Act, organizational conflicts of interest, and OIG exclusion lists.
249-NETWORK Contract Office 9 (36C249)

POSTED

4 days ago

DEADLINE

in 1 day
View Details
NAICS: 541715
New
Federal
MTEC Solicitation Summary: Fiscal Year 2026 Multi-Topic Request for Project Proposals
Solicitation # MTEC-26-04-MultiTopic
The Medical Technology Enterprise Consortium (MTEC), in collaboration with the Defense Health Agency, is soliciting project proposals under solicitation MTEC-26-04-MultiTopic for medical prototype technological and knowledge solutions. Authorized under 10 U.S.C. section 4022 and utilizing an Other Transaction Agreement, this effort seeks to modernize medical capabilities to maintain force readiness and soldier lethality in future multi-domain conflicts. The solicitation covers 16 distinct Focus Areas, including behavioral health, physical fitness, wound infection prevention, sepsis treatment, musculoskeletal injury interventions, non-addictive analgesics, blast and blunt impact sensors, and a multisite clinical biomarker platform for lung and kidney failure. Proposals are submitted via a two-stage Enhanced White Paper process, where selected Stage 1 submissions are invited to provide full cost proposals in Stage 2. To be eligible, projects must demonstrate clear military relevance, meet a minimum Knowledge/Technology Readiness Level of 3, and fit the specific definition of a prototype rather than being exploratory. Additionally, solutions must not have been submitted to MTEC within the last two years. While average initial awards range from 2.0 to 3.5 million dollars over a two to three year period, specific funding and performance periods vary by Focus Area. Teaming is encouraged, and successful projects may be eligible for non-competitive follow-on tasks.
Defense Health Agency

POSTED

4 days ago

DEADLINE

in 17 days
View Details
NAICS: 541715
New
Federal
Atomically Precise Molecules (APM)
Solicitation # DARPA-PS-26-141
The Defense Advanced Research Projects Agency (DARPA) Multi X Office is soliciting proposals for the Atomically Precise Molecules (APM) program under solicitation DARPA-PS-26-141. The program aims to develop innovative synthesis techniques for programmable precision polymers (PPPs) and nonlinear optical (NLO) materials to overcome performance gaps in optical communications and LiDAR. The primary objective is the creation of scalable, fit-for-purpose materials, culminating in a prototype demonstration of a revolutionary NLO material integrated into a government-provided electro-optic modulator. Research focusing solely on inorganic materials or incremental improvements to the state-of-the-art is specifically excluded. This 36-month effort is structured in two technical phases, with Phase I focusing on developing PPP synthesis capabilities over the first 12 months. Awards will be issued as Other Transaction (OT) for Prototype Agreements under 10 U.S.C. 4022. Key requirements include CMMC Level 2 self-assessment compliance and adherence to a program-specific Controlled Unclassified Information (CUI) guide. Non-US organizations, FFRDCs, UARCs, and government entities are ineligible to serve as prime performers, though FFRDCs and UARCs may participate as subawardees provided they meet specific certification and conflict of interest mitigation requirements. Proposals must be submitted via the Broad Agency Announcement Tool (BAAT) by December 18, 2026. Submissions must include a technical and management volume, a price proposal with a detailed spreadsheet, a Task Description Document, and a schedule of milestones and payments. Evaluation will be based on the technical approach, relevance to the DARPA mission, budget realism, and the capability to transition the technology to military or commercial sectors. Payments are milestone-based and processed through the Wide Area Workflow (WAWF) system.
Defense Advanced Research Projects Agcy

POSTED

4 days ago

DEADLINE

in 2 months
View Details
NAICS: 621111
New
Federal
Q999--Kidney Biopsies Interpretation and Brain Autopsy.
Solicitation # 36C26227Q0039
The Department of Veterans Affairs, Network Contracting Office 22, intends to award a sole source, firm-fixed-price contract for a base year plus two option years to the Loma Linda University Pathology Medical Group. This requirement, categorized under NAICS 621111, is being pursued under FAR Part 6.302-1 as there is only one responsible source capable of meeting the specific needs of the Veterans Affairs Medical Center (VAMC) Loma Linda. The primary objective is to secure local nephropathology and neuropathology services to ensure a rapid 24-hour turnaround time, reducing the need for patient rebiopsies and accelerating cause of death determinations for autopsies. The contractor is responsible for providing all labor, materials, equipment, and transportation for kidney biopsy interpretation and brain examinations. Kidney biopsy services include immunofluorescence and H&E slide interpretation to establish clinical diagnoses. Brain examination services involve the dissection of the brain and the interpretation of H&E and other necessary stains. To maintain diagnostic value, the contract mandates that brains be shipped intact for proper grossing. All services must conform to industry standards, and any SDVOSB or VOSB contractors must comply with the limitations on subcontracting per FAR 52.219-14.
262-NETWORK Contract Office 22 (36C262)

POSTED

4 days ago

DEADLINE

in 3 days
View Details
NAICS: 541715
New
Federal
Lunar Enabling Infrastructure Accelerator (LEIA) -Broad Agency Announcement (BAA) NextSTEP-3 Appendix A - Final Solicitation
Solicitation # 80GRC026R0008
The Lunar Enabling Infrastructure Accelerator (LEIA) is a full and open competition solicitation issued by the NASA Glenn Research Center under the NextSTEP-3 Broad Agency Announcement. The program seeks industry partners to design, develop, and demonstrate prototype systems to mature critical lunar and cislunar infrastructure technologies from lower technology readiness levels toward TRL 5-6. The scope is divided into five technical topics: Vertical Solar Arrays, In-Situ Resource Utilization (ISRU) Oxygen from Regolith Production, Radioisotope Stirling Generators, In-Space Advanced Manufacturing, and Innovative Nanomaterials Production. Awards will be firm-fixed-price contracts with an anticipated total period of performance not exceeding three years, with awards expected in the second quarter of fiscal year 2027. Proposals are evaluated based on a pass/fail assessment of relevance and past experience, followed by a scored evaluation of technical merit, which includes the technical approach, execution strategy, work plan, organizational readiness, personnel qualifications, and risk mitigation. Price and business volumes are reviewed for fairness, reasonableness, and risk but are not numerically scored. Offerors must submit a comprehensive proposal package via NASA's EFSS Box, including a detailed work plan in the form of a Statement of Work, an Organizational Conflicts of Interest plan, and required eligibility certifications. All deliverables must adhere to strict NASA security, cybersecurity, and equipment marking standards, with final inspection and acceptance occurring at the destination.
NASA Glenn Research Center

POSTED

4 days ago

DEADLINE

in 3 days
View Details